EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOTSG00005023786
Gene Symbol: IDH2
3 Cross references
200 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOTSG00005029713
Gene Symbol: IDH2
1 Cross references
200 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOTSG00005039605
Gene Symbol: IDH2
1 Cross references
184 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOTSG00005039606
Gene Symbol: IDH2
1 Cross references
184 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOTSG00005043762
Gene Symbol: IDH2
1 Cross references
200 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSOTSG00005014423
Gene Symbol: LOC112217064
3 Cross references
185 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSOTSG00005019560
Gene Symbol: LOC112254647
3 Cross references
185 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOTSG00005036359
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSOTSG00005026889
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSOTSG00005029191
Gene Symbol: KIF11
1 Cross references
196 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOTSG00005003639
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOTSG00005038406
Gene Symbol: KIF5B
1 Cross references
262 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).